SOURCE: CLX Investment Company, Inc.

November 21, 2007 09:16 ET

CLX Investment Company Announces Successful Attendance at MEDICA 2007 - 39th World Forum for Medicine International Trade Fair

Meetings With Current Distributors and Identification of New Potential Acquisition Candidates Result From the Show

MURRIETA, CA--(Marketwire - November 21, 2007) - CLX Investment Company, Inc. (OTCBB: CLXN), which owns 51% of Zonda, Incorporated, a developer and manufacturer of unique diagnostic tests for the medical and non-medical markets, today announced that CEO Vera Leonard and other company representatives have successfully completed their attendance at MEDICA, the world's largest medical trade fair, which was held November 14-17, 2007 in Dusseldorf, Germany.

The MEDICA trade fair, titled the 39th World Forum for Medicine (, featured the latest medical product developments from around the world, and Ms. Leonard was seeking to identify quality medical testing technologies as potential acquisitions for CLX. The 2007 MEDICA event attracted over 4,300 exhibitors from approximately 100 countries around the world.

One purpose of CLX's visit to MEDICA was for Ms. Leonard and Zonda's Director of European Sales, Mr. Pavel Holik, to meet with Zonda's current European distributors. This was the first opportunity for Ms. Leonard, who also serves as CEO of Zonda, to meet face to face with every one of Zonda's European distributors.

Zonda's first medical test, for Chlamydia, is currently sold throughout Europe under the HandiLab brand, and a U.S. launch is being planned.

"I was pleased to find that the current distributors of Zonda's products in Europe were very happy with the product, and I felt that the face to face meetings were extremely beneficial and bode well for the long-term potential of these relationships," stated Ms. Leonard.

Beyond the meetings with Zonda distributors, Ms. Leonard attended MEDICA to identify additional innovative products as potential acquisitions and opportunities for distribution relationships for CLX. CLX intends to acquire, license and distribute innovative medical diagnostic technologies that are ideally suited for further development, regulatory approval and distribution in the United States. The company recently announced a professional services agreement with American Health Partners, LLC (AHP), under which AHP will assist with the launch of medical diagnostic testing in CLX subsidiary operations, including, but not limited to, the Zonda product lines. AHP ( has over 30 years of experience in the marketing and distribution of professional medical products and has experience in preparing products for market launch in the United States.

A senior management representative from AHP accompanied Ms. Leonard to MEDICA to assist in the identification of potential suitable acquisition candidates, as well as those that may be licensed and/or targeted for distribution.

"AHP's experience was invaluable in identifying the best possible candidates, and I am pleased to report that several companies and technologies have already been targeted for additional due diligence and negotiations with management," said Ms. Leonard.

"The candidates ranged from innovative technologies that would still need to be developed into medical diagnostic products, to fully developed products that have already achieved U.S. regulatory approvals and are currently sold in international markets. This range is expected to allow CLX to develop a strategy under which it would have products in various stages of market readiness -- including near-term, mid-term and long-term development.

"We look forward to reporting to CLX shareholders our ongoing progress in each of these areas. At this point, we can say without reservation that the MEDICA visit was well worth the effort, and we expect to see identifiable results from this trip in the near term," Ms. Leonard added.

To sign up to receive information by email directly from CLX Investment Company when new press releases, investor newsletters, SEC filings, or other information is disclosed, please visit

About CLX Investment Company

CLX Investment Company ( holds a 51% equity interest in Zonda, Inc. Information regarding Zonda can be found on its official website, CLX has also invested, and holds a common stock position, in ActionView International, Inc. (, a publicly traded global manufacturer and marketer of "smart" scrolling advertising billboards.

All statements included in this release, including statements regarding potential future plans and objectives of CLX Investments are forward-looking statements. Such statements are necessarily subject to risks and uncertainties, some of which are significant in scope and nature beyond CLX Investments' control. There can be no assurance that such statements will prove accurate. Actual results and future events could differ materially from those anticipated in such statements depending on many factors. Historical results are not necessarily indicative of future performance.

Contact Information

  • Contact:
    Gemini Financial Communications
    A. Beyer
    Email Contact